Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Use of Antiemetic Agents in Acute Gastroenteritis 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease
Your Article Summary
See Latest ArticlesHealth State Values during the First Year of Drug Treatment in Early-Stage Parkinson's Disease: A Prospective, Population-Based, Cohort Study
Drugs & Aging, 10/26/09
Vossius C et al. – Patients with PD had lower SF–6D utility scores than controls at baseline. Patients started on antiparkinsonian drugs had an improvement in mean utility scores of 0.039 from 0.667 to 0.706. The ICER was €45 259 (2007 values) per QALY, of which two–thirds consisted of the costs of drugs and one–third represented the costs of clinical consultations. Drug treatment in patients with early–stage PD increases health state values, but the ICER is high. Further investigations will be necessary to capture the full consequences of treatment of PD and to evaluate the efficacy of disease management in this setting.
Today in Neurology...keeping you current
Receive free subspecialty "5-minute updates" via email
25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services
Neurology, 12/01/09
Outcome of intracerebral haemorrhage patients pre-treated with statins
European Journal of Neurology, 11/17/09
Cardiometabolic Risk of Second-Generation Antipsychotic Medications During First-Time Use in Children and Adolescents
JAMA, 10/29/09
Sponsor
Article Search
Sponsor